Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
morphine lymphocyte antigen 96 small molecule NA drugbank Disease Management[MeSHID:D019468]
Addictive Behavior[MeSHID:D016739]
Disease[MeSHID:D004194]
Physical Examination[MeSHID:D010808]
emotional dependency[MeSHID:D003858]
Drug abuse[MeSHID:D019966]
Patient Monitoring[MeSHID:D008991]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 NA approved,investigational activator
morphine delta-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Addictive Behavior[MeSHID:D016739]
Disease[MeSHID:D004194]
Physical Examination[MeSHID:D010808]
emotional dependency[MeSHID:D003858]
Drug abuse[MeSHID:D019966]
Patient Monitoring[MeSHID:D008991]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.32 approved,investigational agonist
morphine kappa-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Addictive Behavior[MeSHID:D016739]
Disease[MeSHID:D004194]
Physical Examination[MeSHID:D010808]
emotional dependency[MeSHID:D003858]
Drug abuse[MeSHID:D019966]
Patient Monitoring[MeSHID:D008991]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.23 approved,investigational agonist
morphine mu-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Addictive Behavior[MeSHID:D016739]
Disease[MeSHID:D004194]
Physical Examination[MeSHID:D010808]
emotional dependency[MeSHID:D003858]
Drug abuse[MeSHID:D019966]
Patient Monitoring[MeSHID:D008991]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.2 approved,investigational agonist
morphine opioid receptor mu NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Addictive Behavior[MeSHID:D016739]
Disease[MeSHID:D004194]
Physical Examination[MeSHID:D010808]
emotional dependency[MeSHID:D003858]
Drug abuse[MeSHID:D019966]
Patient Monitoring[MeSHID:D008991]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.2 approved agonist
morphine opioid receptor mu NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Addictive Behavior[MeSHID:D016739]
Disease[MeSHID:D004194]
Physical Examination[MeSHID:D010808]
emotional dependency[MeSHID:D003858]
Drug abuse[MeSHID:D019966]
Patient Monitoring[MeSHID:D008991]
Pain[MeSHID:D010146]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic pain[MeSHID:D059350]		 0.2 approved unknown
click here to return to the previous page